• Tidak ada hasil yang ditemukan

DAFTAR PUSTAKA - Repository UNISBA

N/A
N/A
Protected

Academic year: 2024

Membagikan "DAFTAR PUSTAKA - Repository UNISBA"

Copied!
3
0
0

Teks penuh

(1)

43

DAFTAR PUSTAKA

1. Kumar. Robbins Basic Pathology, 9th ed. Elsevier. 2012.

2. WHO 2013. Globocan, 2013. Int Agency Res Cancer, World Heal Organ.

2013;

3. Kemalasari DW, Nilapsari R, Rusmartini T. Korelasi Disfungsi Seksual dengan Usia dan Terapi pada Benign Prostatic Hyperplasia. Glob Med Heal Commun. 2017; Glob Med Heal Commun. 2017;

4. Lim K Bin. Epidemiology of clinical benign prostatic hyperplasia. Asian J Urol [Internet]. 2017;4(3):148–51. Available from:http://dx.doi.org/10.

1016/j.ajur.2017.06.004

5. Filzha A. Gambaran Benigna prostat Hiperplasia di RSUP Prof. Dr. R. D.

Kandou MAnado Periode Januari-Juli 2017. 2016;4(September 2015):127–

31.

6. Mochtar CA, Umbas R, Soebadi DM, Rasyid N, Noegroho BS, Poernomo BB, et al. Pedoman penatalaksanaan klinis pembesaran prostat jinak (benign prostatic hyperplasia / BPH). In 2015. p. 1–27.

7. Manuscript A. NIH Public Access. 2012;82:220–36.

8. Gerber GS, Goldfischer ER, Karrison TG, Bales GT. Serum creatinine measurements in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology.2015;

9. Loho IKA, Rambert GI, Wowor MF, Skripsi K, Kedokteran F, Sam U, et al.

Gambaran kadar ureum pada pasien penyakit ginjal kronik stadium 5 non dialisis. 2016;4.

10. Moore KL, Dalley AF, Agur AMR. Clinically Oriented Anatomy (Seventh Edition). Lippincott Williams & Wilkins, a Wolters Kluwer business. 2014.

11. Mescher AL. Junqueira’s Basic Histology: Text and Atlas, Thirteenth Edition. McGraw-Hill Education. 2013.

::repository.unisba.ac.id::

(2)

44

12. Sherwood L. Fisiologi Manusia dari Sel ke Sistem. Fisiologi Manusia dari Sel ke Sistem. 2013.

13. Purnomo BB. Urology in Asia - Indonesia. Int J Urol. 2011;

14. Nash J. Benign prostatic hyperplasia: risk factors and management. Gerimed Midlife Beyond Urol. 2011;

15. Banerjee PP, Banerjee S, Brown TR, Zirkin BR. Androgen action in prostate function and disease. Am J Clin Exp Urol. 2018;

16. Sampson N, Madersbacher S, Berger P. Pathophysiology and therapy of benign prostatic hyperplasia. Wiener Klinische Wochenschrift. 2012.

17. McAninch JW, Lue TF. Smith & Tanagho’s General Urology. McGraw-Hill.

2013.

18. Roehrborn CG, McConnell J. Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia. Campbell’s Urol. 2012;

19. Cannon GW, Getzenberg RH. Biomarkers for benign prostatic hyperplasia progression. Curr Urol Rep. 2013;

20. Verdiansah. Pemeriksaan Fungsi Ginjal. J Diabetes. 2016;Vol.43 No.(2):148–54.

21. Denise D. Wilson. Manual of Laboratory and Diagnostic Test. McGraw-Hill.

United States; 2011.

22. Biddulth. Pemilihan Modalitas Pemeriksaan Radiologi untuk Diagnosis Benign Prostatic Hyperplasia. 2016;43 no. 6(6):471. Available from:

http://webcache.googleusercontent.com/search?q=cache:eEXBnbQQRNkJ:

www.cdkjournal.com/index.php/CDK/article/download/75/72+&cd=1&hl=

en&ct=clnk&gl=id&client=firefox-b-ab

23. Kaplan SA. Identification of the patient with enlarged prostate: Diagnosis and guidelines for management. Osteopath Med Prim Care. 2011;1:1–6.

::repository.unisba.ac.id::

(3)

45

24. Hasbullah B. Angka Kejadian Komplikasi Lambat Pascaoperasi Prostatektomi Transvesikal dan Reseksi Transuretral pada Pasien Pembesaran Prostat Jinak. Biomedika. 20;1(1):1–5.

25. Issa MM, Thwaites D. Transurethral resection of the prostate (TURP). Med Manag Surg Patient A Textb Perioper Med. 2015;8:787–90.

26. Edlin R.S, Heyns C.F, Van V.S.P, Zarrabi A.D. Prevalence of Histological Prostatistis In Men With Benign Prostatic Hyperplasia or Adenocarcinoma of The Prostate Presenting Without Urinary Retention. 2012 Nov 12;50(4):

127-30

27. Kim wt, Yun sj, Choi yd Kim gy Mon sk, Choi yh, Kim iy, Jae kw. Size Correlates with Fasting Blood Glucose in Non-Diabetic Benign Prostatic Hyperplasia Patients with Normal Testosterone Levels. 2011 Sep 1; (9):

1214-1218)

28. Akdemir A.O, Oztekin C.V, Doluoglu O.G, Karabakan M, Ogulu O, Cetinkaya M. The Effect of Transuretral Resection of The Prostate on Morbidity and Mortality in Patient with Nondialysis-requiring Renal Insufficiency 2012 Apr;4(2):51-56

::repository.unisba.ac.id::

Referensi

Dokumen terkait

Dutasteride is a 5-alpha-reductase inhibitor, used for handling symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate.. Dutasteride works by suppressing

The role of inflammation in prostate diseases is suggested by the presence of inflammatory cells within the Benign Prostatic Hyperplasia (BPH) and Prostate Cancer (PC)..

Latar Belakang: Hingga saat ini, tadalafil telah banyak digunakan untuk manajemen lower urinary tract symptoms (LUTS) akibat benign prostatic hyperplasia

Performed Transurethral Resection of the Prostate Keywords: Benign Prostatic Hyperplasia, TURP, LUTS Symptom PENDAHULUAN BPH sebenarnya adalah istilah histopatologi untuk

Experience in Using Intrauterine Balloon in Early Postpartum Hemorrhage ...19 Mohammad Hashim Kamran Urinary Tract Infection in patients with Benign Prostatic Hyperplasia admitted for

ix HUBUNGAN ANTARA BODY MASS INDEX BMI DAN KADAR SERUM PROSTATE SPECIFIC ANTIGEN PSA TERHADAP GAMBARAN HISTOPATOLOGI BENIGN PROSTATIC HYPERPLASIA BPH DI RSPAD GATOT SOEBROTO PADA

Toriq Abqo, 2023 HUBUNGAN ANTARA BODY MASS INDEX BMI DAN KADAR SERUM PROSTATE SPECIFIC ANTIGEN PSA TERHADAP GAMBARAN HISTOPATOLOGI BENIGN PROSTATIC HYPERPLASIA BPH DI RSPAD GATOT

57 Toriq Abqo, 2023 HUBUNGAN ANTARA BODY MASS INDEX BMI DAN KADAR SERUM PROSTATE SPECIFIC ANTIGEN PSA TERHADAP GAMBARAN HISTOPATOLOGI BENIGN PROSTATIC HYPERPLASIA BPH DI RSPAD